Lotemax 0.5% ophthalmic suspension Images
Generic Name: loteprednol
This medication has been identified as Lotemax 0.5% ophthalmic suspension. It is supplied by Bausch & Lomb Inc.
Lotemax is used in the treatment of Conjunctivitis; Iritis; Cyclitis; Keratitis; Postoperative Ocular Inflammation and belongs to the drug class ophthalmic steroids. Risk cannot be ruled out during pregnancy. Lotemax 0.5% ophthalmic suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Lotemax
- Generic Name
- loteprednol
- Strength
- 0.5% ophthalmic suspension
- Availability
- Prescription only
- Drug Class
- Ophthalmic steroids
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bausch & Lomb Inc.
- National Drug Code (NDC)
- 24208-0299
More about Lotemax (loteprednol ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Patient resources
Other brands
Eysuvis, Alrex, Lotemax SM, Inveltys
Professional resources
- Lotemax prescribing information
- Lotemax Eye Gel (FDA)
- Lotemax Eye Ointment (FDA)
- Loteprednol (AHFS Monograph)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.